In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related death globally. HCC is a complex multistep disease and usually emerges in the setting of chronic liver diseases. The molecular pathogenesis of HCC varies according to the etiology,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/91bcbda415674b97aaf077363f4732ed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91bcbda415674b97aaf077363f4732ed
record_format dspace
spelling oai:doaj.org-article:91bcbda415674b97aaf077363f4732ed2021-11-11T15:36:04ZIn Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling10.3390/cancers132155832072-6694https://doaj.org/article/91bcbda415674b97aaf077363f4732ed2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5583https://doaj.org/toc/2072-6694Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related death globally. HCC is a complex multistep disease and usually emerges in the setting of chronic liver diseases. The molecular pathogenesis of HCC varies according to the etiology, mainly caused by chronic hepatitis B and C virus infections, chronic alcohol consumption, aflatoxin-contaminated food, and non-alcoholic fatty liver disease associated with metabolic syndrome or <i>diabetes mellitus</i>. The establishment of HCC models has become essential for both basic and translational research to improve our understanding of the pathophysiology and unravel new molecular drivers of this disease. The ideal model should recapitulate key events observed during hepatocarcinogenesis and HCC progression in view of establishing effective diagnostic and therapeutic strategies to be translated into clinical practice. Despite considerable efforts currently devoted to liver cancer research, only a few anti-HCC drugs are available, and patient prognosis and survival are still poor. The present paper provides a state-of-the-art overview of in vivo and in vitro models used for translational modeling of HCC with a specific focus on their key molecular hallmarks.Guilherme Ribeiro RomualdoKaat LeroyCícero Júlio Silva CostaGabriel Bacil PrataBart VanderborghtTereza Cristina da SilvaLuís Fernando BarbisanWellington AndrausLindsey DevisscherNiels Olsen Saraiva CâmaraMathieu VinkenBruno CogliatiMDPI AGarticlehepatocarcinogenesisliver canceranimal modelcell culturegene mutationepigenetic alterationNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5583, p 5583 (2021)
institution DOAJ
collection DOAJ
language EN
topic hepatocarcinogenesis
liver cancer
animal model
cell culture
gene mutation
epigenetic alteration
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle hepatocarcinogenesis
liver cancer
animal model
cell culture
gene mutation
epigenetic alteration
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Guilherme Ribeiro Romualdo
Kaat Leroy
Cícero Júlio Silva Costa
Gabriel Bacil Prata
Bart Vanderborght
Tereza Cristina da Silva
Luís Fernando Barbisan
Wellington Andraus
Lindsey Devisscher
Niels Olsen Saraiva Câmara
Mathieu Vinken
Bruno Cogliati
In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
description Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related death globally. HCC is a complex multistep disease and usually emerges in the setting of chronic liver diseases. The molecular pathogenesis of HCC varies according to the etiology, mainly caused by chronic hepatitis B and C virus infections, chronic alcohol consumption, aflatoxin-contaminated food, and non-alcoholic fatty liver disease associated with metabolic syndrome or <i>diabetes mellitus</i>. The establishment of HCC models has become essential for both basic and translational research to improve our understanding of the pathophysiology and unravel new molecular drivers of this disease. The ideal model should recapitulate key events observed during hepatocarcinogenesis and HCC progression in view of establishing effective diagnostic and therapeutic strategies to be translated into clinical practice. Despite considerable efforts currently devoted to liver cancer research, only a few anti-HCC drugs are available, and patient prognosis and survival are still poor. The present paper provides a state-of-the-art overview of in vivo and in vitro models used for translational modeling of HCC with a specific focus on their key molecular hallmarks.
format article
author Guilherme Ribeiro Romualdo
Kaat Leroy
Cícero Júlio Silva Costa
Gabriel Bacil Prata
Bart Vanderborght
Tereza Cristina da Silva
Luís Fernando Barbisan
Wellington Andraus
Lindsey Devisscher
Niels Olsen Saraiva Câmara
Mathieu Vinken
Bruno Cogliati
author_facet Guilherme Ribeiro Romualdo
Kaat Leroy
Cícero Júlio Silva Costa
Gabriel Bacil Prata
Bart Vanderborght
Tereza Cristina da Silva
Luís Fernando Barbisan
Wellington Andraus
Lindsey Devisscher
Niels Olsen Saraiva Câmara
Mathieu Vinken
Bruno Cogliati
author_sort Guilherme Ribeiro Romualdo
title In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
title_short In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
title_full In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
title_fullStr In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
title_full_unstemmed In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
title_sort in vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/91bcbda415674b97aaf077363f4732ed
work_keys_str_mv AT guilhermeribeiroromualdo invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT kaatleroy invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT cicerojuliosilvacosta invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT gabrielbacilprata invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT bartvanderborght invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT terezacristinadasilva invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT luisfernandobarbisan invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT wellingtonandraus invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT lindseydevisscher invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT nielsolsensaraivacamara invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT mathieuvinken invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
AT brunocogliati invivoandinvitromodelsofhepatocellularcarcinomacurrentstrategiesfortranslationalmodeling
_version_ 1718435195812577280